AI-FIRST PROGRAMMABLE
MOLECULAR INFRASTRUCTURE

Building the next generation of drug conjugates and targeted therapeutics — by programming how molecules are designed, conjugated, and controlled in the body.

Explore Our Platform

What We Build

Drug Conjugates & Targeted Therapeutics

Designing next-generation drug conjugates — including ADCs, PDCs, and degrader conjugates — with improved stability, selectivity, and therapeutic index through programmable molecular architecture.

Programmable Linker Systems

Engineering precision linker and conjugation systems that improve stability, controllability, and payload release kinetics — the critical interface between drug and carrier.

MolForge — AI Design Platform

Our proprietary AI/ML platform integrates computational molecular design, experimental validation, and scalable development workflows to accelerate the discovery and optimization of conjugated molecules.

Our Mission

Programming Molecules to Improve Human Health

AracodeX integrates computational molecular design, experimental validation, and scalable development workflows to enable next-generation drug conjugates and targeted therapeutics. Over time, we believe this infrastructure can support broader programmable molecular applications across biomedicine and advanced materials.

Learn More About Us